Certified by Founder Lodge
Ascenta Capital
United States - ND
INVESTOR
1 Disclosed Funding Rounds $200,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ascenta Capital invests in biotechs.
| Company | Date | Round | Raised |
|---|---|---|---|
 ADARx Pharmaceuticals Inc. |
August, 10 ,2023 | Series C | $200,000,000 |
 Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Alpha-9 Oncology |
October, 24 ,2024 | Series C | $175,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Brellium | $13,700,000 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
GoldState Music | $500,000,000 | (Apr 22, 2025)
